By Pragyan Kalita Sept 25 (Reuters) – Shares of ADARx Pharmaceuticals rose 30% above their initial public offering price on Friday after the late-stage gene therapy developer raised $446.3 million in
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Anthropic investor Lonsdale says AI firms stoking fear to sway policy
By Joe Brock AUSTIN, Sept 25 (Reuters) - Joe Lonsdale, an investor in Anthropic and the…
REUTERS NEXT-FTC chair suggests AI developers should be liable for conduct of agents
By Jody Godoy AUSTIN, Sept 25 (Reuters) - US Federal Trade Commission Chairman Andrew Ferguson…
Margot Robbie quietly changes surname to Ackerley in new business documents
Los Angeles [US], September 25 (ANI): Actor Margot Robbie has seemingly changed her surname to…
